ArticleJTO clinical and research reports2024

Long-Term Efficacy of Immune Checkpoint Inhibitor for Squamous Cell Carcinoma Lesion Transformed From

Shota Takahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.